Kendall Capital Partners — Full Portfolio

Biotechnology company using multiplex gene editing to develop genetically engineered porcine organs for human transplantation.

BiotechBrookline, US

Luhan Yang(President, Secretary and Treasurer)Geoff MacKay(Chief Executive Officer)

Board seatGeorge M. Church· per SEC Form D · $3M raise · filed Aug 2016

Co-investorsAlta PartnersARCH Venture PartnersCatalio Capital Management, LPKhosla VenturesOUP (Osage University Partners)b2venture

EpiBone engineers bone tissue from stem cells for regenerative medicine and clinical reconstruction, serving patients requiring bone grafts or craniofacial repair.

BiotechHealthtechMedical DevicesNew York, US

Nina Tandon(Co-Founder, CEO)inSarindr Bhumiratana(Co-Founder)inGordana Vunjak-Novakovic(Director)Elma Hawkins(Director)

BoardDavid Zhu(Director)in

Board seatRobert Langer· per SEC Form D

Co-investorsBeresford VenturesEMV CapitalHackensack Meridian Health Bear's DenPlum Alley InvestmentsTachyon VenturesTech Council Ventures

BiotechWoburn, US

David Lucchino(Executive Officer, Director)inChristopher R. Loose(Executive Officer)

BoardMarc Kozin(Director)Marc Cohen(Director)Timothy Barberich(Director)

Board seatRobert Langer· per SEC Form D · $62M raise · filed Jul 2019

Co-investorsvenBio PartnersAlexandria

BiotechWatertown, US

Carlo Giovanni Traverso(Director)Amy W. Schulman(Executive Officer, Director)inRobert S. Langer(Director)

BoardZafi Avnur(Director)Edmund Harrigan(Director)Catherine Reynolds(Director)

Board seatRobert Langer· per SEC Form D · $23.1M raise · filed Apr 2017

Co-investorsBill & Melinda Gates FoundationGilead SciencesInvusPolaris Partners

HealthtechLexington, US

Robert S. Langer(Director)Michael J. Cima(Director)David Neafus(Executive Officer)Cheryl R. Blanchard(Executive Officer, Director)Robert Farra(Executive Officer)

BoardTerrance G. McGuire(Director)

Board seatRobert Langer· per SEC Form D · $18.6M raise · filed Jun 2015

Co-investorsPolaris Partners

A biotech company developing a multi-layered polymer delivery system for sustained-release vaccine and medication administration via single injection.

BiotechCambridge, US

Ana Jacklenec(Director, Promoter)Robert Farra(Executive Officer, Director)

BoardDavid Zhu(Director)Felicia Hsu(Director)

Board seatRobert Langer· per SEC Form D

BiotechCambridge, US

Torben Straight Nissen(Executive Officer, Director)inJoanne Protano(Executive Officer)inDavid Epstein(Director)Harvey F. Lodish(Director)Michael Rosenblatt(Director)Roger Pomerantz(Director)

Board seatRobert Langer· per SEC Form D · $120M raise · filed Jun 2017

Co-investorsFlagship PioneeringFlagship Ventures

BiotechWatertown, US

Omid Farokhzad(Director)inRobert S. Langer, Jr.(Director)Omid C. Farokhzad(Director)inRobert S. Langer(Director)Andrew J. Fromkin(Executive Officer, Director)Leila Alland(Executive Officer)in

Board seatRobert Langer· per SEC Form D · $38M raise · filed Feb 2017

Co-investors+ND CapitalNew Enterprise Associates (NEA)

Eyenuk provides autonomous AI-based eye exams performed at the point of care to detect eye conditions including diabetic retinopathy (DR), age-related macular degeneration (AMD), and glaucomatous signs.

AI & Machine LearningDigital HealthHealthtechMedical DevicesWoodland Hills, US

Kaushal Solanki(Founder; Director, PhD)inGaurav Agarwal(Chief Executive Officer)in

BoardMads Dall(Director)Zina Affas Besse(Director)Marie-Louise Little(Director)

Rejuvenate Bio develops gene therapy treatments aimed at the root causes of aging to address chronic, age-related conditions such as osteoarthritis, heart disease, and cancer.

BiotechHealthtechLongevitySan Diego, US

Noah Davidsohn(CSO, Co-Founder)inDaniel Oliver(CEO, Co-Founder)inGeorge Church(Co-Founder and SAB)Deborah Ascheim(Chief Medical Officer)in

BoardDavid Zhu(Director)in

Co-investorsCompanion FundConnecticut InnovationsDigitalis VenturesKdT Ventures